ABSTRACT Although glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have demonstrated considerable efficacy in the treatment of diabetes and obesity, it is essential to recognize that their use is associated with certain intrinsic risks that must not be disregarded
Some patients pay significantly less than list price through various programs, while others face substantial out-of-pocket costs
Additionally, naltrexone can precipitate withdrawal symptoms in patients with recent opioid exposure, a consideration independent of GLP-1 use but critical to assess before starting naltrexone
95% CI, 0.35 to 3.14)
Keeping food choices predictable can reduce overwhelm and help you stay nourished even when hunger feels different than usual
However, Wegovy sold in other regions (e.g., UK, Europe) often comes in adjustable FlexTouch pens, similar to Ozempic